The Commoditization Of GLP-1s: Why Viking's Maintenance Hedge Is Falling Short [Seeking Alpha]
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026
2 Biotech Stocks Set to Rebound in 2026 [Yahoo! Finance]
Why Viking Therapeutics (VKTX) Is Down 6.5% After Publishing VK2735 Phase 2 Obesity Trial Results And What's Next [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX) Advances Obesity Drug Development and Expands Metabolic Disease Pipeline [Yahoo! Finance]